Overview

Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension)

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The scientific aim of the present extension study is to monitor long-term safety and tolerability of idebenone in patients with DMD. Furthermore, the long-term effect on respiratory, cardiac and motor functions, and skeletal muscle strength/function will be assessed.
Phase:
Phase 2
Details
Lead Sponsor:
Santhera Pharmaceuticals
Treatments:
Idebenone
Ubiquinone